Skip to content

Do You Know How to Spot SARMs?

In April, the US Senate introduced the SARMs Control Act of 2018, which would empower the Drug Enforcement Administration (DEA) to regulate selective androgen receptor modulators (SARMs) as an extension of the Designer Anabolic Steroids Control Act of 2014. Few people understand what SARMs are, and even fewer know how to spot them. This becomes problematic for payment facilitators onboarding merchants selling bodybuilding and weight-loss products online because there is a risk that the website is facilitating the sale of SARMs.

It's important to know not only what SARMs are but how to spot them. Well-meaning payment facilitators can experience expensive card brand fines if even one product on a merchant's website contains an unapproved drug such as SARMs. The problem is that SARMs or products containing SARMs are not always easy to spot.

First of all, many products may appear to be dietary supplements for use in bodybuilding but aren't clearly identified as containing SARMs. Below is a screenshot of a website selling Adonis, Athena, and Black Magic, products that all purport to contain SARMs, though it's not readily apparent by their names - you have to look at the ingredients listed below.

Second, SARMs come in many forms, including liquid, powder, pills, and capsules. There is no easy way to quickly identify whether a product contains a SARM just by looking at its form.

Because product names and forms don't immediately identify SARMs, it's important to look at product ingredient labels. But even these can be confusing because some products that sound like SARMs (and may even function like them) are not technically SARMs. For example, the following substances are some popular SARMs:

  • LGD-4033 (also known as Ligandrol, VK5211)
  • MK-2866 (also known as Enobosarm, Ostarine)
  • RAD-140 (also known as Testolone)
  • S-4 (also known as Andarine)

However, the following ingredients, though frequently marketed and sold as SARMs, are not technically SARMs. They are experimental compounds that produce effects similar to SARMs and are frequently lumped in with SARMs by government agencies, but are, nonetheless, not technically SARMs.

  • GW-501516 (also known Cardarine, Endurobol)
  • SR-9009
  • MK-677 (also known Ibutamoren)

These substances are, with few exceptions, just as problematic and potentially dangerous as SARMs (and sometimes even more so).

Being able to properly identify SARMs takes experts who are familiar with these products and who keep on top of regulatory news regarding unapproved drugs. Merchants offering SARMs for human consumption may face legal action, and payment providers who onboard these merchants are at risk for card brand fines. Alongside the world's largest database of problematic products, LegitScript has a team of leading experts that keeps abreast of new products such as SARMs and tracks the regulatory and card brand trends that follow.

Interested in learning more? Download our full SARMs FAQ guide.

 

Recent Blog Articles

Where Policy Meets Performance: Winning in Healthcare Advertising Post-Certification

Why LegitScript Certification Matters for Healthcare Advertising For many healthcare providers, earning LegitScript Certification is a major milestone. It's the key that unlocks advertising on platforms like Google and Meta, two of the most powerful digital channels for reaching patients. Certificat...

Key Takeaways from the 2025 Marketplace Risk New York Conference

The 2025 Marketplace Risk New York Conference proved that marketplaces and platforms are no longer simply about connecting buyers and sellers. They are about creating safe, trusted environments where commerce can thrive. For trust and safety, compliance, legal, and product professionals, the message...

Why the Next 6 Months Will Redefine Merchant Risk Management

Two deadlines. One turning point. On October 1, 2025, enforcement begins on the Visa Acquirer Monitoring Program (VAMP). Just three months later, on January 1, 2026, Mastercard's Merchant Monitoring Program (MMP) revised standards take effect. Together, these updates mark one of the most significant...

Maverick Payments and LegitScript Weigh in on AI’s Growing Role in Payments

Artificial intelligence (AI) may be one of the hottest topics in payment processing, but industry leaders say its role in payments is an opportunity that requires a thoughtful approach and critical thinking. That was the central theme of LegitScript's recent webinar, "Maverick Payments on What AI Re...